Keep informed of the latest news and blog posts from ALSA Ventures by subscribing to our newsletter.
As we step into the second year of COVID-19 it begs the question; has the pandemic that has shaken the earth changed the investing habits of venture capitalists? Here, investment and deal activity in the COVID era is compared to the pre-COVID era, with a focus on oncology, infectious diseases and CNS disorders.Read More
Seriously - who in the life sciences community at the end of 2019 would have predicted “a pandemic scare” in their top ten predictions for the biotech sector in 2020? Well, Brad Loncar, CEO of Loncar Investments and former advisor to the U.S. Department of the Treasury, for one. What does not seem to have been predicted, however, is just how resilient – indeed buoyant – the healthcare sector would turn out to be in the face of a Worldwide viral pandemic causing one of the most formidable Global economic downturns in living memory.Read More
The coronavirus pandemic has shone a light on the biotechnology sector, thereby propelling the names of relatively unknown biotechnology companies which have hitherto been confined to the vernacular of those connected with the industry, into the mainstream.Read More